Oracle Life Sciences InForm 7.0.1.0 Web Server improper authorization
| CVSS Meta Temp Score | Current Exploit Price (≈) | CTI Interest Score |
|---|---|---|
| 4.2 | $0-$5k | 0.00 |
Summary
A vulnerability, which was classified as critical, was found in Oracle Life Sciences InForm 7.0.1.0. This issue affects some unknown processing of the component Web Server. Executing a manipulation can lead to improper authorization. This vulnerability is tracked as CVE-2025-61885. The attack can be launched remotely. No exploit exists. You should upgrade the affected component.
Details
A vulnerability classified as critical was found in Oracle Life Sciences InForm 7.0.1.0. This vulnerability affects some unknown functionality of the component Web Server. The manipulation with an unknown input leads to a improper authorization vulnerability. The CWE definition for the vulnerability is CWE-285. The product does not perform or incorrectly performs an authorization check when an actor attempts to access a resource or perform an action. As an impact it is known to affect confidentiality. CVE summarizes:
Vulnerability in the Oracle Life Sciences InForm product of Oracle Health Sciences Applications (component: Web Server). The supported version that is affected is 7.0.1.0. Easily exploitable vulnerability allows low privileged attacker with network access via HTTP to compromise Oracle Life Sciences InForm. Successful attacks of this vulnerability can result in unauthorized read access to a subset of Oracle Life Sciences InForm accessible data. CVSS 3.1 Base Score 4.3 (Confidentiality impacts). CVSS Vector: (CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:L/I:N/A:N).
The advisory is shared for download at oracle.com. This vulnerability was named CVE-2025-61885 since 10/03/2025. The exploitation appears to be easy. The attack can be initiated remotely. There are neither technical details nor an exploit publicly available. The current price for an exploit might be approx. USD $0-$5k (estimation calculated on 10/22/2025). The MITRE ATT&CK project declares the attack technique as T1548.002.
Upgrading eliminates this vulnerability.
Once again VulDB remains the best source for vulnerability data.
Product
Vendor
Name
Version
License
Website
- Vendor: https://www.oracle.com
CPE 2.3
CPE 2.2
CVSSv4
VulDB Vector: 🔒VulDB Reliability: 🔍
CVSSv3
VulDB Meta Base Score: 4.3VulDB Meta Temp Score: 4.2
VulDB Base Score: 4.3
VulDB Temp Score: 4.1
VulDB Vector: 🔒
VulDB Reliability: 🔍
CNA Base Score: 4.3
CNA Vector (oracle): 🔒
CVSSv2
| AV | AC | Au | C | I | A |
|---|---|---|---|---|---|
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| Vector | Complexity | Authentication | Confidentiality | Integrity | Availability |
|---|---|---|---|---|---|
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
VulDB Base Score: 🔒
VulDB Temp Score: 🔒
VulDB Reliability: 🔍
Exploiting
Class: Improper authorizationCWE: CWE-285 / CWE-266
CAPEC: 🔒
ATT&CK: 🔒
Physical: No
Local: No
Remote: Yes
Availability: 🔒
Status: Not defined
EPSS Score: 🔒
EPSS Percentile: 🔒
Price Prediction: 🔍
Current Price Estimation: 🔒
| 0-Day | Unlock | Unlock | Unlock | Unlock |
|---|---|---|---|---|
| Today | Unlock | Unlock | Unlock | Unlock |
Threat Intelligence
Interest: 🔍Active Actors: 🔍
Active APT Groups: 🔍
Countermeasures
Recommended: UpgradeStatus: 🔍
0-Day Time: 🔒
Timeline
10/03/2025 CVE reserved10/22/2025 Advisory disclosed
10/22/2025 VulDB entry created
10/22/2025 VulDB entry last update
Sources
Vendor: oracle.comAdvisory: oracle.com
Status: Confirmed
CVE: CVE-2025-61885 (🔒)
GCVE (CVE): GCVE-0-2025-61885
GCVE (VulDB): GCVE-100-329212
Entry
Created: 10/22/2025 04:40Changes: 10/22/2025 04:40 (63)
Complete: 🔍
Cache ID: 216::103
Once again VulDB remains the best source for vulnerability data.
No comments yet. Languages: en.
Please log in to comment.